Role of Serological and Immunological Methods in Diagnosing the Causes of Infiltrative Syndrome

What is Infiltrative Syndrome?

1. Serological Markers for Specific Causes

A. Sarcoidosis

• Serum Angiotensin-Converting Enzyme (ACE): The most widely used serum marker. Elevated in ~60% of acute sarcoidosis and only ~20% of chronic disease, reflecting granuloma burden. Elevations >50% above the upper limit of normal are seen in only a few conditions: sarcoidosis, leprosy, Gaucher's disease, hyperthyroidism, and disseminated granulomatous infections (miliary TB). Sensitivity is limited; cannot be used alone. ACE inhibitor use invalidates the test (Harrison's, p. 10324).
• Serum soluble IL-2 receptor (sIL-2R / sCD25): More sensitive than ACE, reflects T-lymphocyte activation; useful for monitoring disease activity.
• Serum lysozyme: Elevated in active disease; less specific than ACE.
• Hypercalcemia / elevated 1,25-(OH)₂D₃: Due to extrarenal hydroxylation by activated macrophages in granulomas; supports diagnosis.
• Elevated serum ferritin: Nonspecific but seen in active disease.
• Bronchoalveolar lavage (BAL) immunology: CD4:CD8 ratio >3.5 is highly supportive of sarcoidosis (sensitivity ~53%, specificity ~94%).

B. Tuberculosis and Miliary TB

• Interferon-Gamma Release Assays (IGRAs) — QuantiFERON-TB Gold, T-SPOT.TB: Detect T-cell IFN-γ response to M. tuberculosis-specific antigens (ESAT-6, CFP-10). High specificity; unaffected by BCG vaccination. Essential for diagnosing latent and active TB in immunocompetent patients.
• Tuberculin Skin Test (Mantoux / PPD): Detects delayed-type hypersensitivity (Type IV). Sensitivity reduced in miliary TB and immunosuppression.
• Adenosine deaminase (ADA): Elevated in pleural fluid, CSF, and BAL in TB; reflects T-lymphocyte activation.
• Serum ACE: Elevated in miliary TB (as noted above), helping distinguish from sarcoidosis in the right context.
• Serological antibody tests (anti-TB IgG/IgM): Generally low sensitivity/specificity; not recommended as standalone diagnostics.

C. Fungal Infections

D. Parasitic / Protozoal Causes

• Chagas disease (T. cruzi): Chronic infection diagnosed by IgG serology — ELISA and IFA are primary methods. No single test is sufficient; two tests based on different antigens (e.g., whole parasite lysate ELISA + recombinant antigen IFA) are required to confirm. A single positive result does not constitute confirmed diagnosis (OI Guidelines, p. 64).
• Toxocara / visceral larva migrans: ELISA for IgG anti-Toxocara (larval excretory/secretory antigens).
• Echinococcosis: ELISA + confirmatory IHA or western blot for Echinococcus antibodies.
• Schistosomiasis: Serum ELISA (IgG) against adult worm antigen.

E. Autoimmune / Connective Tissue Disease-Associated ILD

F. Neoplastic Causes (Lymphoma)

• LDH: Elevated in high-grade lymphoma; reflects tumor burden.
• Beta-2 microglobulin: Elevated in NHL and myeloma; prognostic marker.
• Serum protein electrophoresis (SPEP) + immunofixation: Detects monoclonal proteins (M-spike) in myeloma or lymphoplasmacytic lymphoma with pulmonary involvement.
• Flow cytometry of BAL, blood, or pleural fluid: Immunophenotyping of lymphocyte populations — essential for lymphoma subclassification.
• Serum free light chains (kappa/lambda ratio): Myeloma and plasma cell dyscrasias.

G. Storage / Metabolic Diseases

• Gaucher's disease: Elevated serum ACE (as noted), elevated chitotriosidase, and glucocerebrosidase enzyme activity assay in leukocytes; plasma CCL18.
• Amyloidosis: Serum free light chains, SPEP, SAP scintigraphy (specialized centers).

2. Immunological Methods in Detail

Enzyme-Linked Immunosorbent Assay (ELISA)

Immunofluorescence (IFA / ANCA testing)

• Indirect immunofluorescence on HEp-2 cells for ANA, ANCA
• Pattern (c-ANCA vs. p-ANCA) directs further ELISA confirmation (PR3/MPO)
• Microimmunofluorescence for Chlamydia and other intracellular pathogens

Complement Fixation (CF)

Immunodiffusion (Ouchterlony)

Western Blot / Immunoblot

Interferon-Gamma Release Assays (IGRAs)

Flow Cytometry

• BAL: CD4:CD8 ratio (sarcoidosis >3.5; hypersensitivity pneumonitis <1.0)
• Blood/tissue lymphocyte immunophenotyping in lymphoma
• T-cell subset counting (CD4 count in HIV-related infiltrates)

Antigen Detection

• Cryptococcus CrAg (latex agglutination, LFA)
• Histoplasma urine/serum antigen (EIA)
• Aspergillus galactomannan
• Pneumocystis β-D-glucan These are particularly valuable in immunocompromised patients where antibody responses may be blunted.

3. Practical Diagnostic Algorithm

Infiltrative Syndrome (radiological)
        |
        ├─ Clinical context: immunocompromised? → HIV serology, CD4 count
        |       → Opportunistic infections panel (Cryptococcus CrAg, β-D-glucan,
        |         Histoplasma Ag, CMV PCR, IGRA)
        |
        ├─ Systemic features / connective tissue signs?
        |       → ANA, ANCA (c/p), anti-dsDNA, anti-Scl-70, anti-Jo-1,
        |         anti-CCP, RF, complement
        |
        ├─ Occupational/environmental exposure?
        |       → Precipitating IgG antibody panel (HP antigens)
        |
        ├─ Bilateral hilar lymphadenopathy / uveitis / hypercalcemia?
        |       → Serum ACE, sIL-2R, BAL CD4:CD8, Ca²⁺, 1,25-(OH)₂D
        |
        ├─ Fever, weight loss, night sweats, travel history?
        |       → IGRA/TST, serum fungal antigens, blood cultures,
        |         malaria smear, Chagas ELISA+IFA
        |
        └─ Constitutional symptoms + lymphadenopathy + LDH?
                → LDH, β2-microglobulin, SPEP, flow cytometry,
                  biopsy with immunohistochemistry

4. Limitations of Serological/Immunological Methods

Summary

• ACE / sIL-2R for sarcoidosis
• IGRA for tuberculosis
• Fungal antigen/antibody panels for endemic mycoses and opportunistic fungi
• ANA/ANCA/myositis/SSc antibody panels for connective tissue diseases
• ELISA + IFA (two independent tests) for parasitic diseases such as Chagas
• LDH, β2-MG, flow cytometry for lymphoproliferative causes